As of 2024-12-14, the Intrinsic Value of Prestige Consumer Healthcare Inc (PBH) is
106.53 USD. This PBH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 82.30 USD, the upside of Prestige Consumer Healthcare Inc is
29.40%.
The range of the Intrinsic Value is 70.02 - 203.43 USD
106.53 USD
Intrinsic Value
PBH Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
70.02 - 203.43 |
106.53 |
29.4% |
| DCF (Growth 10y) |
75.65 - 199.56 |
109.84 |
33.5% |
| DCF (EBITDA 5y) |
76.36 - 173.45 |
103.71 |
26.0% |
| DCF (EBITDA 10y) |
80.91 - 174.18 |
107.86 |
31.1% |
| Fair Value |
104.20 - 104.20 |
104.20 |
26.61% |
| P/E |
86.00 - 123.04 |
104.08 |
26.5% |
| EV/EBITDA |
66.41 - 182.66 |
88.57 |
7.6% |
| EPV |
62.96 - 93.60 |
78.28 |
-4.9% |
| DDM - Stable |
39.64 - 126.46 |
83.05 |
0.9% |
| DDM - Multi |
46.18 - 115.67 |
66.14 |
-19.6% |
PBH Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
4,066.44 |
| Beta |
0.41 |
| Outstanding shares (mil) |
49.41 |
| Enterprise Value (mil) |
5,066.70 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.16% |
| Cost of Debt |
4.67% |
| WACC |
6.40% |